Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Chemoradiation for organ preservation in the treatment of muscle-invasive bladder cancer.
Journal: Urologic oncology
Published: November 22, 2015
Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 19, 2015
An open-label, single-arm, phase 2 trial of the Polo-like kinase inhibitor volasertib (BI 6727) in patients with locally advanced or metastatic urothelial cancer.
Journal: Cancer
Published: August 27, 2013
The effect of prior androgen synthesis inhibition on outcomes of subsequent therapy with docetaxel in patients with metastatic castrate-resistant prostate cancer: results from a retrospective analysis of a randomized phase 3 clinical trial (CALGB 90401) (Alliance).
Journal: Cancer
Published: April 11, 2013
Associations between medical student log data and clerkship learning outcomes.
Journal: Teaching and learning in medicine
Published: October 06, 2012
Randomized, double-blind, placebo-controlled phase III trial comparing docetaxel and prednisone with or without bevacizumab in men with metastatic castration-resistant prostate cancer: CALGB 90401.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 29, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026